EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection

Maria Vinokurova, Maria Elisa Lopes-Pires, Neringa Cypaite, Fisnik Shala, Paul C Armstrong, Blerina Ahmetaj-Shala iD, Youssef Elghazouli, Rolf Nüsing, Bin Liu iD, Yingbi Zhou iD, Chuan-Ming Hao iD, Harvey R Herschman und 2 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024

DOI: 10.1161/atvbaha.123.318923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Maria Vinokurova und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, United Kingdom (M.V., M.E.L.-P., N.C., F.S., B.A.-S., Y.E., J.A.M., N.S.K.). Hauptthemen laut MEDLINE: Epoprostenol, Thrombosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prostacyclin is a fundamental signaling pathway traditionally associated with the cardiovascular system and protection against thrombosis but which also has regulatory functions in fibrosis, proliferation, and immunity. Prevailing dogma states that prostacyclin is principally derived from vascular endothelium, although it is known that other cells can also synthesize it. However, the role of nonendothelial sources in prostacyclin production has not been systematically evaluated resulting in an underappreciation of their importance relative to better characterized endothelial sources. METHODS: To address this, we have used novel endothelial cell–specific and fibroblast-specific COX (cyclo-oxygenase) and prostacyclin synthase knockout mice and cells freshly isolated from mouse and human lung tissue. We have assessed prostacyclin release by immunoassay and thrombosis in vivo using an FeCl 3 -induced carotid artery injury model. RESULTS: We found that in arteries, endothelial cells are the main source of prostacyclin but that in the lung, and other tissues, prostacyclin production occurs largely independently of endothelial and vascular smooth muscle cells. Instead, in mouse and human lung, prostacyclin production was strongly associated with fibroblasts. By comparison, microvascular endothelial cells from the lung showed weak prostacyclin synthetic capacity compared with those isolated from large arteries. Prostacyclin derived from fibroblasts and other nonendothelial sources was seen to contribute to antithrombotic protection. CONCLUSIONS: These observations define a new paradigm in prostacyclin biology in which fibroblast/nonendothelial-derived prostacyclin works in parallel with endothelium-derived prostanoids to control thrombotic risk and potentially a broad range of other biology. Although generation of prostacyclin by fibroblasts has been shown previously, the scale and systemic activity was unappreciated. As such, this represents a basic change in our understanding and may provide new insight into how diseases of the lung result in cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpoprostenolThrombosisMiceHumansAnimalsFibrinolytic AgentsEndothelial CellsProstaglandins IEndothelium, VascularMice, KnockoutFibroblasts

Stichwörter der Autor:innen

endothelial cellsfibroblastsimmunoassayrisk factorsthrombosis

Substanzen

EpoprostenolFibrinolytic AgentsProstaglandins I

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, United Kingdom (M.V., M.E.L.-P., N.C., F.S., B.A.-S., Y.E., J.A.M., N.S.K.).
  • Blizard Institute, Queen Mary University of London, United Kingdom (P.C.A.).
  • Clinical Pharmacology and Pharmacotherapy Department, Goethe University, Frankfurt, Germany (R.N.).
  • Cardiovascular Research Centre, Shantou University Medical College, China (B.L., Y.Z.).
  • Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China (C.-m.H.).
  • Department of Molecular and Medical Pharmacology, University of California Los Angeles (H.R.H.).

ORCID-Profile: Blerina Ahmetaj-Shala, Bin Liu, Yingbi Zhou, Chuan-Ming Hao, Nicholas S Kirkby

Förderung

  • British Heart Foundation
  • NCI NIH HHS

Zitieren

APA

Vinokurova, M., Lopes-Pires, M. E., Cypaite, N., Shala, F., Armstrong, P. C., Ahmetaj-Shala, B., Elghazouli, Y., Nüsing, R., Liu, B., Zhou, Y., Hao, C. M., Herschman, H. R., Mitchell, J. A., & Kirkby, N. S. (2024). Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.318923

Vancouver

Vinokurova M, Lopes-Pires ME, Cypaite N, Shala F, Armstrong PC, Ahmetaj-Shala B, et al. Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.318923

BibTeX
@article{Vinokurova2024,
  author = {Vinokurova, Maria and Lopes-Pires, Maria Elisa and Cypaite, Neringa and Shala, Fisnik and Armstrong, Paul C and Ahmetaj-Shala, Blerina and Elghazouli, Youssef and Nüsing, Rolf and Liu, Bin and Zhou, Yingbi and Hao, Chuan-Ming and Herschman, Harvey R and Mitchell, Jane A and Kirkby, Nicholas S},
  title = {Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  doi = {10.1161/atvbaha.123.318923}
}
Kostenlos starten →